Pharma Journalist 7836 posts 0 comments

1CellBiO Inc announced today a research collaboration with UCB to validate and deploy the inDrop™ high throughput single cell RNA sequencing platform in order to better understand the…
Read More...

KYORIN Holdings, Inc. announced today that its wholly owned subsidiary, KYORIN Pharmaceutical Co., Ltd., has entered into a license agreement with Merck & Co., Inc., Kenilworth,…
Read More...

Neurocrine Biosciences’ Ingrezza (valbenazine) capsules has been approved by US FDA (food and Drug Administration) for treatment of tardive dyskinesia (TD). TD is characterised by…
Read More...

OncoMed Pharmaceuticals’ demcizumab (anti-DLL4, OMP-21M18) has failed to meet its primary endpoint in the Phase 2 YOSEMITE clinical trial in combination with Abraxane (paclitaxel…
Read More...

The U.S. Food and Drug Administration today approved supplemental applications for Sovaldi (sofosbuvir) and Harvoni (ledipasvir and sofosbuvir) to treat hepatitis C virus (HCV) in…
Read More...

PeptiDream Inc., a public Tokyo-based biopharmaceutical company announced today that it has entered into a multi-target discovery and optimization collaboration with US-based Janssen…
Read More...

Accenture announced its collaboration with BioCelerate to Advance Biopharmaceutical Innovations through Increased Insights in Research & Development. The R&D data sharing…
Read More...

Takeda Pharmaceutical Company Limited announced a strategic collaboration with NuBiyota LLC for the development of Microbial Ecosystem Therapeutic products for gastroenterology (GI)…
Read More...

Medivir has reported positive data from its phase II clinical trial of the topical, skin-directed histone deacetylase (HDAC) inhibitor, remetinostat, in early stage Cutaneous T-cell…
Read More...

No group of stakeholders wields greater influence over patient access to medicines than payers making reimbursement and formulary decisions. Even in a time of policy upheaval in …
Read More...